According to the authors, a decrease in the CD4/CD8 ratio is inherently associated with an increased risk of developing diseases, including cancers, proving to be a strong indicator of high levels of immune activation, replicative senescence and T cell exhaustion (Macêdo Santiago et al., 2018). The gene discussed is CD4; the disease is cancer.